Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/10221284
Conclusion of this study
Preliminary observations suggest that chromium may potentiate antidepressant pharmacotherapy for dysthymic disorder. Controlled studies are indicated to test the validity of these initial observations.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
